Holen Sie sich die Stockscreener-App
313.30
2.39%
-7.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$320.96
Offen:
$303.83
24-Stunden-Volumen:
12.79M
Relative Volume:
1.16
Marktkapitalisierung:
$391.80B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
59.14
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
-10.57%
1M Leistung:
-16.27%
6M Leistung:
+40.52%
1J Leistung:
+210.84%
1-Tages-Spanne:
$298.65
$322.07
1-Wochen-Bereich:
$298.65
$357.25
52-Wochen-Spanne:
$90.73
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
313.30 | 401.38B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,747.58 | 685.57B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
529.66 | 445.36B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
212.75 | 286.56B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
322.36 | 50.45B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
SEB Asset Management AB Buys Shares of 443,913 Lam Research Corporation $LRCX - MarketBeat
Copeland Capital Management LLC Has $11.13 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research stock trades steady as investors weigh memory spending recovery and recent earnings bea - ad-hoc-news.de
Lam Research stock steadies as investors weigh foundry demand and capital spending cycle - ad-hoc-news.de
Lam Research Corp. stock underperforms Friday when compared to competitors - MarketWatch
Lam Research stock trades steady as memory demand and China curbs shape outlook - ad-hoc-news.de
Lam Research and Intel among market cap stock movers on Friday - Investing.com Australia
Lam Research and Intel among market cap stock movers on Friday By Investing.com - Investing.com South Africa
Lam Research Corporation (LRCX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
US512807AX6 Bond Profile — Key Metrics - TradingView
Lam Research Corporation $LRCX Shares Purchased by Bessemer Group Inc. - MarketBeat
Lam Research stock trades near record levels as memory demand supports outlook - Ad Hoc News
Moderate Bearish Sentiment Surrounds Lam Research (LRCX) Amid Pr - GuruFocus
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Semtech and Lam Research Shares Plummet, What You Need To Know - Barchart.com
Net debt of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Lam Research stock trades near record levels as memory orders support growth - ad-hoc-news.de
Cash flow from investing activities of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Cash flow from financing activities of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Lam Research stock trades steadily as chip-equipment demand supports recent earnings - ad-hoc-news.de
Lam Research Corp Stock (LRCX) Moved Down by 3.59% on Jul 16: Drivers Behind the Movement - TradingKey
Lam Research Corporation $LRCX Shares Bought by Noesis Capital Mangement Corp - MarketBeat
Operating income of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh - TradingView
Net income of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Twin Capital Management Inc. Purchases 8,407 Shares of Lam Research Corporation $LRCX - MarketBeat
Sigma Planning Corp Sells 4,260 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Position Lessened by Bank of New York Mellon Corp - MarketBeat
Lam Research Corp (1LRCX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Lam Research Corp (1LRCX) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Lam Research Corp (1LRCX) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Enterprise value to EBITDA ratio of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Book value per share of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Net current asset value per share of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Cash per share of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
CapEx per share of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Lam Research Corp Stock (LRCX) Moved Down by 6.34% on Jul 15: A Full Analysis - TradingKey
TD Cowen Raises PT on Lam Research (LRCX), Keeps a Buy - Yahoo Finance
UBS Raises Lam Research Price Target to $435 From $375, Maintains Buy Rating - Moomoo
Lam Research Corp (LRCX:CT): Stock Price, Quote and News - BNN Bloomberg
Lam Research and Nova Shares Are Soaring, What You Need To Know - Yahoo Finance
Lam Research director Abhijit Talwalkar sells $6.1m in company stock - Investing.com Nigeria
Mizuho Raises its Price Target on Lam Research Corporation (LRCX) - Yahoo Finance
Is Lam Research Corp (LRCX) Overvalued After 4.9% Rally? GF Valu - GuruFocus
Lam Research Rises as Chip-Equipment Sentiment Improves Ahead of Earnings - Quiver Quantitative
Form 4 Lam Research Corp For: 14 July By Investing.com - Investing.com South Africa
Goldman Sachs, Lam Research among market cap stock movers on Tuesday - Investing.com Nigeria
Lam Research director Abhijit Talwalkar sells $6.1m in company stock By Investing.com - Investing.com India
Lam Research (NASDAQ:LRCX) Director Sells $6,124,470.00 in Stock - MarketBeat
Lam Research Insider Sold Shares Worth $6,124,470, According to a Recent SEC Filing - Moomoo
Lam Research Corp (LRCX) director sells 18,282 shares under 10b5-1 plan - Stock Titan
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.57%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):